|
1
|
Liu J, Yi J, Zhang Z, Cao D, Li L and Yao
Y: Deoxyribonuclease 1-like 3 may be a potential prognostic
biomarker associated with immune infiltration in colon cancer.
Aging (Albany NY). 13:16513–16526. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Troncone E, Marafini I, Stolfi C and
Monteleone G: Involvement of Smad7 in inflammatory diseases of the
gut and colon cancer. Int J Mol Sci. 22:39222021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Finotti M, Vitale A, Gringeri E, D'Amico
FE, Boetto R, Bertacco A, Lonardi S, Bergamo F, Feltracco P and
Cillo U: Colon rectal liver metastases: The role of the liver
transplantation in the Era of the transplant oncology and precision
medicine. Front Surg. 8:6933872021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tauriello DVF, Palomo-Ponce S, Stork D,
Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, Sevillano M,
Ibiza S, Cañellas A, Hernando-Momblona X, et al: TGFβ drives immune
evasion in genetically reconstituted colon cancer metastasis.
Nature. 554:538–543. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Araghi M, Arnold M, Rutherford MJ, Guren
MG, Cabasag CJ, Bardot A, Ferlay J, Tervonen H, Shack L, Woods RR,
et al: Colon and rectal cancer survival in seven high-income
countries 2010-2014: Variation by age and stage at diagnosis (the
ICBP SURVMARK-2 project). Gut. 70:114–126. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qin Q, Yang L, Sun YK, Ying JM, Song Y,
Zhang W, Wang JW and Zhou AP: Comparison of 627 patients with
right- and left-sided colon cancer in China: Differences in
clinicopathology, recurrence, and survival. Chronic Dis Transl Med.
3:51–59. 2017.PubMed/NCBI
|
|
7
|
Gao J, Yang M, Liu L, Guo S, Li Y and
Cheng C: The aggressive surgical treatment and outcome of a colon
cancer patient with COVID-19 in Wuhan, China. BMC Gastroenterol.
20:2692020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao M, Li H, Sun D and Chen W: Cancer
burden of major cancers in China: A need for sustainable actions.
Cancer Commun (Lond). 40:205–210. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Villalba M, Evans SR, Vidal-Vanaclocha F
and Calvo A: Role of TGF-β in metastatic colon cancer: It is
finally time for targeted therapy. Cell Tissue Res. 370:29–39.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Kloet ER, Van Acker SA, Sibug RM, Oitzl
MS, Meijer OC, Rahmouni K and de Jong W: Brain mineralocorticoid
receptors and centrally regulated functions. Kidney Int.
57:1329–1336. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu M, Yu HL, Li QH, Zhang L and Chen YX:
miR-4709 overexpression facilitates cancer proliferation and
invasion via downregulating NR3C2 and is an unfavorable prognosis
factor in colon adenocarcinoma. J Biochem Mol Toxicol.
33:e224112019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tiberio L, Nascimbeni R, Villanacci V,
Casella C, Fra A, Vezzoli V, Furlan L, Meyer G, Parrinello G,
Baroni MD, et al: The decrease of mineralcorticoid receptor drives
angiogenic pathways in colorectal cancer. PLoS One. 8:e594102013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Wang X, Li Z, Zhang Z and Zhang Y:
Chemokine receptor 7 targets the vascular endothelial growth factor
via the AKT/ERK pathway to regulate angiogenesis in colon cancer.
Cancer Med. 8:5327–5340. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang S, He P, Wang J, Schetter A, Tang W,
Funamizu N, Yanaga K, Uwagawa T, Satoskar AR, Gaedcke J, et al: A
novel MIF signaling pathway drives the malignant character of
pancreatic cancer by targeting NR3C2. Cancer Res. 76:3838–3850.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Wu X and She W: lncRNA POU3F3
promotes cancer cell migration and invasion in nasopharyngeal
carcinoma by up-regulating TGF-β1. Biosci Rep. 39:BSR201816322019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Agraval H and Yadav UCS: MMP-2 and MMP-9
mediate cigarette smoke extract-induced epithelial-mesenchymal
transition in airway epithelial cells via EGFR/Akt/GSK3β/β-catenin
pathway: Amelioration by fisetin. Chem Biol Interact.
314:1088462019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Han F, Liu W and Shi X: PTBP1
promotes tumorigenesis by regulating apoptosis and cell cycle in
colon cancer. Bull Cancer. 105:1193–1201. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Z, Che X, Yang N, Bai Z, Wu Y, Zhao
L and Pei H: miR-135b-5p Promotes migration, invasion and EMT of
pancreatic cancer cells by targeting NR3C2. Biomed Pharmacother.
96:1341–1348. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang C, Ma X, Guan G, Liu H, Yang Y, Niu
Q, Wu Z, Jiang Y, Bian C, Zang Y and Zhuang L: MicroRNA-766
promotes cancer progression by targeting NR3C2 in hepatocellular
carcinoma. FASEB J. 33:1456–1467. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Z, Zhang M, Duan X, Deng T, Qiu H and
Zeng G: Low NR3C2 levels correlate with aggressive features and
poor prognosis in non-distant metastatic clear-cell renal cell
carcinoma. J Cell Physiol. 233:6825–6838. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Muche A, Bigl M, Arendt T and Schliebs R:
Expression of vascular endothelial growth factor (VEGF) mRNA, VEGF
receptor 2 (Flk-1) mRNA, and of VEGF co-receptor neuropilin (Nrp)-1
mRNA in brain tissue of aging Tg2576 mice by in situ hybridization.
Int J Dev Neurosci. 43:25–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mizuno R, Kawada K, Itatani Y, Ogawa R,
Kiyasu Y and Sakai Y: The role of tumor-associated neutrophils in
colorectal cancer. Int J Mol Sci. 20:5292019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boeckx N, Janssens K, Van Camp G,
Rasschaert M, Papadimitriou K, Peeters M and Op de Beeck K: The
predictive value of primary tumor location in patients with
metastatic colorectal cancer: A systematic review. Crit Rev Oncol
Hematol. 121:1–10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng JQ, Ruggeri B, Klein WM, Sonoda G,
Altomare DA, Watson DK and Testa JR: Amplification of AKT2 in human
pancreatic cells and inhibition of AKT2 expression and
tumorigenicity by antisense RNA. Proc Natl Acad Sci USA.
93:3636–3641. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cargnello M and Roux PP: Activation and
function of the MAPKs and their substrates, the MAPK-activated
protein kinases. Microbiol Mol Biol Rev. 75:50–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gu Y, Wang Q, Guo K, Qin W, Liao W, Wang
S, Ding Y and Lin J: TUSC3 promotes colorectal cancer progression
and epithelial-mesenchymal transition (EMT) through WNT/β-catenin
and MAPK signalling. J Pathol. 239:60–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen H, Feng J, Zhang Y, Shen A, Chen Y,
Lin J, Lin W, Sferra TJ and Peng J: Pien Tze Huang inhibits
hypoxia-induced angiogenesis via HIF-1 α/VEGF-a pathway in
colorectal cancer. Evid Based Complement Alternat Med.
2015:4542792015.PubMed/NCBI
|
|
29
|
Wang R, Luo Z, Zhang H and Wang T:
Tanshinone IIA reverses gefitinib-resistance in human
non-small-cell lung cancer via regulation of VEGFR/Akt pathway.
Onco Targets Ther. 12:9355–9365. 2019. View Article : Google Scholar : PubMed/NCBI
|
